Skip to main content
GutCited

Peppermint Oil Irritable Bowel Syndrome (IBS)

A

Meta-analyses of 12+ RCTs demonstrate peppermint oil (450-750 mg/day enteric-coated) significantly reduces IBS abdominal pain (RR 1.78 vs placebo). A-grade evidence for global IBS symptom improvement. ACG conditional recommendation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dpeppermint\u002Doil\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

結論

Meta-analyses of 12+ RCTs demonstrate peppermint oil (450-750 mg/day enteric-coated) significantly reduces IBS abdominal pain (RR 1.78 vs placebo). A-grade evidence for global IBS symptom improvement. ACG conditional recommendation.

Key Study Findings

Review
Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
Dose: None vs: None Outcome: None 効果: None None

対象集団: patients with IBS (review of plant extracts including peppermint oil, Iberogast, curcumin)

Review
European Consensus on Functional Bloating and Abdominal Distension-An ESNM/UEG Recommendations for Clinical Management.
Dose: None vs: None Outcome: Functional bloating and abdominal distension management 効果: None None

対象集団: Patients with functional bloating/distension (consensus)

Review
Mechanisms of action and clinical effectiveness of herbal treatments for disorders of gut-brain interaction.
Dose: None vs: Placebo Outcome: GI symptoms in DGBI (FD, IBS) 効果: None None

対象集団: Patients with functional dyspepsia and IBS (review)

Review
Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.
Dose: None vs: None Outcome: None 効果: None None

対象集団: Review of herbal remedies for IBS

Review
Diet, nutraceuticals, and lifestyle interventions for the treatment and management of irritable bowel syndrome.
Dose: None vs: None Outcome: IBS symptom management 効果: None None

対象集団: Patients with IBS (review)

Review
Natural Products for the Treatment of Irritable Bowel Syndrome.
Dose: None vs: None Outcome: None 効果: None None

対象集団: Patients with irritable bowel syndrome

Key Statistics

19

研究数

2569

参加者数

Positive

A

グレード

Referenced Papers

Journal of clinical … 2025 8 件の引用
The Medical letter … 2025
Current pharmaceutical design 2023 12 件の引用
Alimentary pharmacology & … 2022 35 件の引用
Neurogastroenterology and motility 2022 11 件の引用
Alimentary pharmacology & … 2022 1 件の引用
Frontline gastroenterology 2021 56 件の引用
Neurogastroenterology and motility 2020 34 件の引用
Gastroenterology 2020 8 件の引用
The Medical letter … 2020
Current gastroenterology reports 2019 18 件の引用
Journal of gastroenterology … 2017 32 件の引用
Current opinion in … 2017 24 件の引用
Current gastroenterology reports 2017 16 件の引用
Handbook of experimental … 2017 4 件の引用
American journal of … 2016 15 件の引用
Digestion 2014 61 件の引用
Journal of gastroenterology 2014 47 件の引用
Irritable bowel syndrome. Systematic Review
BMJ clinical evidence 2012 6 件の引用
Journal of clinical … 2011 30 件の引用
European journal of … 2010 61 件の引用
Irritable bowel syndrome. Systematic Review
BMJ clinical evidence 2010
Canadian family physician … 2009 108 件の引用
Australian family physician 2009 12 件の引用
American family physician 2007 125 件の引用
Current treatment options … 2006 24 件の引用
Pediatrics in review 2006 2 件の引用
Phytomedicine : international … 2005 72 件の引用
American family physician 2005
The American journal … 1998 266 件の引用
The American journal … 1998 13 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
450-750 mg/day enteric-coated capsules
ibssymptomsupport:
187-225 mg enteric-coated capsules, 2-3 times daily, 30-60 min before meals

上限量: Well-tolerated up to 1,200 mg/day in clinical trials; enteric coating essential

研究で検討された用量

用量 期間 効果 N
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Mixed --

推奨摂取タイミング: 30-60 minutes before meals; enteric-coated capsules MUST be swallowed whole (do not chew or crush)

Safety & Side Effects

報告されている副作用

  • Heartburn/GERD exacerbation (if non-enteric-coated; relaxes lower esophageal sphincter)
  • Perianal burning sensation (from undigested menthol reaching the rectum)
  • Nausea at high doses
  • Allergic reactions in mint-sensitive individuals

既知の相互作用

  • Cyclosporine (peppermint may increase cyclosporine levels via CYP3A4 inhibition)
  • Antacids and PPIs (may dissolve enteric coating prematurely; space 2 hours)
  • Simethicone (coated formulations may interact with enteric-coated peppermint)
  • CYP2C19 substrates (menthol is a weak CYP inhibitor)

耐容上限摂取量: Well-tolerated up to 1,200 mg/day in clinical trials; enteric coating essential

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Peppermint Oil help with Irritable Bowel Syndrome (IBS)?
Based on 19 studies with 2,569 participants, there is strong evidence from multiple clinical trials that Peppermint Oil may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is A (Strong Evidence).
How much Peppermint Oil should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 450-750 mg/day enteric-coated capsules. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Peppermint Oil?
Reported side effects may include Heartburn/GERD exacerbation (if non-enteric-coated; relaxes lower esophageal sphincter), Perianal burning sensation (from undigested menthol reaching the rectum), Nausea at high doses, Allergic reactions in mint-sensitive individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Peppermint Oil and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 19 peer-reviewed studies with 2,569 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。